Lapsed Jul 3, 2026 on the fee record · High confidence
20-year base term ends Jun 12, 2033
Second maintenance fee unpaid; grace period ended.
Held by Quiapeg Pharmaceuticals AB
Filed Dec 12, 2014 as application 14/407,580 · Granted Jul 3, 2018
Base term, 20 years from filing, plus 218 days of patent term adjustment (USPTO delay)
Today
Lapsed Jul 3, 2026
2013
2034
Clock starts
Jun 12, 2013
Jun 12, 2013
No longer in force
Jul 3, 2026
Jul 3, 2026
Granted
Jul 3, 2018
Jul 3, 2018
Term would have run to
Jan 16, 2034
Jan 16, 2034
base term
patent term adjustment
after the term ends
fee events
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
218
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
6
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
Its term would have run to Jan 16, 2034: its 20-year base term plus 218 days of term adjustment for prosecution delay. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jun 12, 2013, when application PCT/IB2013/001885, the earliest non-provisional in its chain, was filed (this one was filed Dec 12, 2014) | Jun 12, 2033 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +218 days, USPTO patent term adjustment record | Jan 16, 2034 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 3 maintenance fees paid | lapsed Jul 3, 2026 | High confidence |
| Computed term end | The steps above, in order | Jul 3, 2026 | High confidence |
This family
| US 10,010,621 | this patent Jul 2026 | Jul 2026 |
| US 10,383,946 | In force Jun 2033 | Jun 2033 |
| US 10,806,796 | Lapsed on the fee record Oct 2024 | Oct 2024 |
| US 11,510,989 | In force Jun 2033 | Jun 2033 |
| Application 17/974,258 | Abandoned not computed | not computed |
5 of 6 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Mar 8, 2018 Reel 45147, frame 594 | Kwiatkowski, Marek | Quiapeg AB | Assignment of Assignor's Interest |
| Jan 2, 2019 Reel 48000, frame 10 | Quiapeg AB | Quiapeg Pharmaceuticals AB | Change of Name |
| Mar 31, 2020 Reel 52277, frame 452 | Kwiatkowski, Marek | Quiapeg AB | Assignment of Assignor's Interest |
| Mar 31, 2020 Reel 52277, frame 485 | Kwiatkowski, Marek | Quiapeg Pharmaceuticals AB | Assignment of Assignor's Interest |
| Mar 31, 2020 Reel 52280, frame 24 | Quiapeg AB | Quiapeg Pharmaceuticals AB | Change of Name |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Note
The 218 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
15
later US patents cite this one
That is top 25% of utility patents granted in 2018 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.